Drug
Fty720
Fty720: highest development phase Post-Market, developed by Novartis. 1 trial record tracked on RxWires.
- Highest phase
- Post-Market
- Developer
- Novartis
Trials
| Drug | Phase | Indication |
|---|---|---|
| FTY720 NCT01585298 | Post-Market | Multiple Sclerosis |
Latest
No recent events.
Follow Fty720 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.